News

Video game technology is being applied to imaging by German researchers, who will be presenting their findings at RSNA 2013. Xbox in the operating room and the use of video game controllers...

clinical trial study cath lab structural heart neovasc reducer cosira

Neovasc Inc. reported the results from its COSIRA (coronary sinus reducer for treatment of refractory angina) trial...

ultrasound systems cardiovascular esaote prevention suite euroecho RF

Esaote will showcase Prevention Suite, a unique package of ultrasound imaging modalities for both...

renal stenting

The use of renal stenting in combination with medication-based therapy to treat hypertension showed no improvement in patient outcomes over the use of medications alone in treating hypertension....

laa occluders structural heart atrial fibrillation atricure atriclip exclusion

AtriCure Inc., a developer of solutions to treat atrial fibrillation, announced the U.S. Food and Drug Administration’s (FDA’s) approval to begin enrollment in a clinical study of AtriCure’s...

Fractional flow reserve (FFR) is considered the gold standard in determining the hemodynamic significance of coronary lesions, but its use remains low. Two new technologies may help increase its...

heart valve repair structural hybrid or medtronic corevalve edwards lifesciences

A German court ordered Nov. 14 the discontinuation of a prior court ruling that prohibited Medtronic from commercially marketing or selling the CoreValve transcatheter aortic ...

heart valve repair hybrid or TAVI boston scientific lotus aortic repair system

The first two commercial implants of the Boston Scientific Lotus Valve System have taken place in a...

The U.S. Food and Drug Administration (FDA) has classified the Medtronic’s recently initiated voluntary recall of certain interventional ...

intravascular imaging ffr ultrasound ivus optical coherence tomography oct cath

In an expert consensus document e-published in Catheterization and Cardiovascular Interventions (CCI), the Society for Cardiovascular Angiography and Interventions (...

Resverlogix Corp. announced two additional results from the ongoing analysis of its Phase 2b ASSURE clinical trial...

Neovasc, Tiara, Tiara Mitral Valve, heart valve repair

Neovasc Inc. announced that the first patent covering the company's innovative Tiara transcatheter mitral valve replacement technology has been issued by the U.S. Patent and Trademark Office. The...

Professional cardiovascular societies and many working cardiologists question the U.S. Food and Drug Administration’s (FDA’s) recent recommendation that patients undergo genetic testing before...

balloon catheters cath lab drug-eluting clinical trials angioscore angiosculpt

AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease...

cardiovascular ultrasound systems accessories rsna 2013 patient positioning CID

Clear Image Devices LLC (CiD) announced the release of its step platform to be used for standing patient ...

cath lab radial access SCAI

The Society for Cardiovascular Angiography and Interventions (SCAI) published a first-of-its-kind paper defining best practices for the use of the transradial approach for diagnosing and treating...

clinical trial study stents cath lab mguard inspiremd

InspireMD Inc., a developer of embolic protection stents, announced 12-month results from the MGuard for Acute ST Elevation Reperfusion (MASTER) ...

Petr Neuzil, M.D., Nemocnice Na Homolce Hospital, Prague, Czech Republic, presented three-month results from the WAVE II study and complete six-month results for the WAVE I (first-in-man) at the...

No law prevents doctors from freely prescribing U.S. Food and Drug Administration (FDA)-approved drugs and devices for off-label uses, yet regulators continue to aggressively pursue civil and...

renal denervation clinical trial study hypertension cath medtronic symplicity

Medtronic Inc. announced that the U.S. Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE), allowing the company to initiate SYMPLICITY HTN-4, the first...